Literature DB >> 25836596

BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.

Ram Fridlich1, Devi Annamalai1, Rohini Roy1, Giana Bernheim1, Simon N Powell2.   

Abstract

BRCA1 and BRCA2 mutation carriers are predisposed to develop breast and ovarian cancers, but the reasons for this tissue specificity are unknown. Breast epithelial cells are known to contain elevated levels of oxidative DNA damage, triggered by hormonally driven growth and its effect on cell metabolism. BRCA1- or BRCA2-deficient cells were found to be more sensitive to oxidative stress, modeled by treatment with patho-physiologic concentrations of hydrogen peroxide. Hydrogen peroxide exposure leads to oxidative DNA damage induced DNA double strand breaks (DSB) in BRCA-deficient cells causing them to accumulate in S-phase. In addition, after hydrogen peroxide treatment, BRCA deficient cells showed impaired Rad51 foci which are dependent on an intact BRCA1-BRCA2 pathway. These DSB resulted in an increase in chromatid-type aberrations, which are characteristic for BRCA1 and BRCA2-deficient cells. The most common result of oxidative DNA damage induced processing of S-phase DSB is an interstitial chromatid deletion, but insertions and exchanges were also seen in BRCA deficient cells. Thus, BRCA1 and BRCA2 are essential for the repair of oxidative DNA damage repair intermediates that persist into S-phase and produce DSB. The implication is that oxidative stress plays a role in the etiology of hereditary breast cancer.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BRCA; Cancer; Chromosome aberrations; Homologous recombination; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25836596      PMCID: PMC4442488          DOI: 10.1016/j.dnarep.2015.03.002

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  67 in total

1.  DNA polymerase beta is required for efficient DNA strand break repair induced by methyl methanesulfonate but not by hydrogen peroxide.

Authors:  P Fortini; B Pascucci; F Belisario; E Dogliotti
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  Genetic analysis of BRCA1 function in a defined tumor cell line.

Authors:  R Scully; S Ganesan; K Vlasakova; J Chen; M Socolovsky; D M Livingston
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks.

Authors:  Thomas M Marti; Eli Hefner; Luzviminda Feeney; Valerie Natale; James E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

4.  Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway.

Authors:  Chiara Gorrini; Bevan P Gang; Christian Bassi; Andrew Wakeham; Shakiba Pegah Baniasadi; Zhenyue Hao; Wanda Y Li; David W Cescon; Yen-Ting Li; Sam Molyneux; Nadia Penrod; Mathieu Lupien; Edward E Schmidt; Vuk Stambolic; Mona L Gauthier; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 5.  BRCA1 and BRCA2: different roles in a common pathway of genome protection.

Authors:  Rohini Roy; Jarin Chun; Simon N Powell
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

6.  Perturbed gap-filling synthesis in nucleotide excision repair causes histone H2AX phosphorylation in human quiescent cells.

Authors:  Megumi Matsumoto; Kie Yaginuma; Ai Igarashi; Mayumi Imura; Mizuho Hasegawa; Kuniyoshi Iwabuchi; Takayasu Date; Toshio Mori; Kanji Ishizaki; Katsumi Yamashita; Manabu Inobe; Tsukasa Matsunaga
Journal:  J Cell Sci       Date:  2007-02-27       Impact factor: 5.285

7.  Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.

Authors:  N Foray; V Randrianarison; D Marot; M Perricaudet; G Lenoir; J Feunteun
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

8.  Lymphoblasts of women with BRCA1 mutations are deficient in cellular repair of 8,5'-Cyclopurine-2'-deoxynucleosides and 8-hydroxy-2'-deoxyguanosine.

Authors:  Henry Rodriguez; Pawel Jaruga; Dennis Leber; Simon G Nyaga; Michele K Evans; Miral Dizdaroglu
Journal:  Biochemistry       Date:  2007-02-09       Impact factor: 3.162

9.  Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.

Authors:  Deniz Simsek; Amy Furda; Yankun Gao; Jérôme Artus; Erika Brunet; Anna-Katerina Hadjantonakis; Bennett Van Houten; Stewart Shuman; Peter J McKinnon; Maria Jasin
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

10.  Rad51 accumulation at sites of DNA damage and in postreplicative chromatin.

Authors:  S Tashiro; J Walter; A Shinohara; N Kamada; T Cremer
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

View more
  23 in total

1.  Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation.

Authors:  Anson Snow; Charite Ricker; Gino K In
Journal:  BMJ Case Rep       Date:  2019-06-20

2.  APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency.

Authors:  Cheng-Yu Tsai; Si Sun; Hongying Zhang; Andrea Local; Yongxuan Su; Larry A Gross; William G Rice; Stephen B Howell
Journal:  Mol Cancer Ther       Date:  2018-04-06       Impact factor: 6.261

Review 3.  Excessive Reactive Oxygen Species and Exotic DNA Lesions as an Exploitable Liability.

Authors:  Safnas F AbdulSalam; Fathima Shazna Thowfeik; Edward J Merino
Journal:  Biochemistry       Date:  2016-09-13       Impact factor: 3.162

4.  An engineered cell line lacking OGG1 and MUTYH glycosylases implicates the accumulation of genomic 8-oxoguanine as the basis for paraquat mutagenicity.

Authors:  Preechaya Tajai; Bogdan I Fedeles; Tawit Suriyo; Panida Navasumrit; Jantamas Kanitwithayanun; John M Essigmann; Jutamaad Satayavivad
Journal:  Free Radic Biol Med       Date:  2017-12-28       Impact factor: 7.376

Review 5.  DNA Damage Response in Prostate Cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

6.  Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer".

Authors:  Sharon B Cantor
Journal:  DNA Repair (Amst)       Date:  2021-08-13

7.  Transferrin facilitates the formation of DNA double-strand breaks via transferrin receptor 1: the possible involvement of transferrin in carcinogenesis of high-grade serous ovarian cancer.

Authors:  S Shigeta; M Toyoshima; K Kitatani; M Ishibashi; T Usui; N Yaegashi
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

Review 8.  BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer.

Authors:  Maja Sedic; Charlotte Kuperwasser
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.

Authors:  Angelo Taglialatela; Giuseppe Leuzzi; Vincenzo Sannino; Raquel Cuella-Martin; Jen-Wei Huang; Foon Wu-Baer; Richard Baer; Vincenzo Costanzo; Alberto Ciccia
Journal:  Mol Cell       Date:  2021-09-10       Impact factor: 19.328

Review 10.  The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms.

Authors:  Marta Falcinelli; Premal H Thaker; Susan K Lutgendorf; Suzanne D Conzen; Renée L Flaherty; Melanie S Flint
Journal:  Cancer Res       Date:  2021-07-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.